Performance status and depressive symptoms as predictors of quality of life in cancer patients. A structural equation modeling analysis

Psycho-Oncology

Volumn 24, Issue 11, 2015, Pages 1456-1462

  Faller, Hermann ^a   Brähler, Elmar ^b,c   Härter, Martin ^d   Keller, Monika ^e   Schulz, Holger ^d   Wegscheider, Karl ^d   Weis, Joachim ^f   Boehncke, Anna ^f   Richard, Matthias ^a   Sehner, Susanne ^d   Koch, Uwe ^d   Mehnert, Anja ^b,d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; DEPRESSION; DEPRESSION ASSESSMENT; FEMALE; FUNCTIONAL STATUS; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; PATIENT HEALTH QUESTIONNAIRE; PREDICTIVE VALUE; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; STRUCTURAL EQUATION MODELING; COMORBIDITY; MIDDLE AGED; NEOPLASMS; PSYCHOLOGY; THEORETICAL MODEL;

ADULT; AGED; COMORBIDITY; DEPRESSION; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASMS; QUALITY OF LIFE;

EID: 84946474992     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3811     Document Type: Article

References (40)

1. Mitchell AJ, Chan M, Bhatti H, et al,. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011; 12: 160-174.
2. Howard-Anderson J, Ganz PA, Bower JE, Stanton AL,. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst 2012; 104: 386-405.
3. Mehnert A, Vehling S, Scheffold K, et al,. Prevalence of adjustment disorder, acute and posttraumatic stress disorders as well as somatoform disorders in cancer patients. Psychother Psychosom Med Psychol 2013; 63: 466-472.
4. Vehling S, Koch U, Ladehoff N, et al,. Prevalence of affective and anxiety disorders in cancer: systematic literature review and meta-analysis. Psychother Psychosom Med Psychol 2012; 62: 249-258.
5. Montazeri A,. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008; 27:32.
6. Brown LF, Kroenke K, Theobald DE, Wu J, Tu W,. The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain. Psycho-Oncology 2010; 19: 734-741.
7. Chan JY, Lua LL, Starmer HH, Sun DQ, Rosenblatt ES, Gourin CG,. The relationship between depressive symptoms and initial quality of life and function in head and neck cancer. Laryngoscope 2011; 121: 1212-1218.
8. Gray NM, Hall SJ, Browne S, et al,. Modifiable and fixed factors predicting quality of life in people with colorectal cancer. Br J Cancer 2011; 104: 1697-1703.
9. Kroenke K, Theobald D, Wu J, Loza JK, Carpenter JS, Tu W,. The association of depression and pain with health-related quality of life, disability, and health care use in cancer patients. J Pain Symptom Manage 2010; 40: 327-341.
10. Reich M, Lesur A, Perdrizet-Chevallier C,. Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 2008; 110: 9-17.
11. Reid-Arndt SA, Yee A, Perry MC, Hsieh C,. Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors. J Psychosoc Oncol 2009; 27: 415-434.
12. Reyes-Gibby CC, Anderson KO, Morrow PK, Shete S, Hassan S,. Depressive symptoms and health-related quality of life in breast cancer survivors. J Womens Health 2012; 21: 311-318.
13. Wettergren L, Bjorkholm M, Axdorph U, Langius-Eklof A,. Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma. Qual Life Res 2004; 13: 1369-1379.
14. Allart P, Soubeyran P, Cousson-Gelie F,. Are psychosocial factors associated with quality of life in patients with haematological cancer? A critical review of the literature. Psycho-Oncology 2013; 22: 241-249.
15. Luutonen S, Sintonen H, Stormi T, Salminen E,. Health-related quality of life during adjuvant radiotherapy in breast cancer. Qual Life Res 2014; 23: 1363-1369.
16. Hyphantis T, Almyroudi A, Paika V, Degner LF, Carvalho AF, Pavlidis N,. Anxiety, depression and defense mechanisms associated with treatment decisional preferences and quality of life in non-metastatic breast cancer: a 1-year prospective study. Psycho-Oncology 2013; 22: 2470-2477.
17. Arden-Close E, Pacey A, Eiser C,. Health-related quality of life in survivors of lymphoma: a systematic review and methodological critique. Leuk Lymphoma 2010; 51: 628-640.
18. Murphy BA, Ridner S, Wells N, Dietrich M,. Quality of life research in head and neck cancer: a review of the current state of the science. Crit Rev Oncol Hematol 2007; 62: 251-267.
19. Frick E, Tyroller M, Panzer M,. Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: a cross-sectional study in a community hospital outpatient centre. Eur J Cancer Care 2007; 16: 130-136.
20. Mosher CE, DuHamel KN, Rini C, Corner G, Lam J, Redd WH,. Quality of life concerns and depression among hematopoietic stem cell transplant survivors. Support Care Cancer 2011; 19: 1357-1365.
21. Karnofsky DA, Burchenal JH,. The clinical evaluation of chemotherapeutic agents in cancer. In Evaluation of Chemotherapeutic Agents, McLeod CM, (ed.). Columbia Univ Press: New York, 1949; 191-205.
22. Pinquart M, Koch A, Eberhardt B, Brix C, Wedding U, Röhrig B,. Associations of functional status and depressive symptoms with health-related quality of life in cancer patients. Qual Life Res 2006; 15: 1565-1570.
23. Wedding U, Koch A, Röhrig B, et al,. Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy. Acta Oncol 2008; 47: 56-62.
24. Mazanec SR, Daly BJ, Douglas SL, Lipson AR,. The relationship between optimisms and quality of life in newly diagnosed cancer patients. Cancer Nurs 2010; 33: 235-243.
25. Oken MM, Creech RH, Tormey DC, et al,. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
26. Mehnert A, Koch U, Schulz H, et al,. Prevalence of mental disorders, psychosocial distress and need for psychosocial support in cancer patients-study protocol of an epidemiological multi-center study. BMC Psychiatry 2012; 12:70.
27. Kroenke K, Spitzer RL, Williams JB,. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613.
28. Mehnert A, Brähler E, Faller H, et al,. Four-week prevalence of mental disorders in cancer patients across major tumor entities. J Clin Oncol 2014; 32: 3540-3546.
29. Löwe B, Spitzer RL, Gräfe K, et al,. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord 2004; 78: 131-140.
30. Aaronson NK, Ahmedzai S, Bergman B, et al,. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
31. Buccheri G, Ferrigno D, Tamburini M,. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 1996; 32: 1135-1141.
32. Schaafsma J, Osoba D,. The Karnofsky performance status scale re-examined: a cross-validation with the EORTC-C30. Qual Life Res 1994; 3: 413-424.
33. Kline RB,. Principles and Practice of Structural Equation Modelling (2nd ed.), Guilford: New York, 2005.
34. Steiger JH,. Understanding the limitations of global fit assessment in structural equation modelling. Pers Indiv Differ 2007; 42: 893-898.
35. Faller H, Störk S, Schuler M, et al,. Depression and disease severity as predictors of health-related quality of life in patients with chronic heart failure-a structural equation modeling approach. J Card Fail 2009; 15: 286-292.
36. Müller-Tasch T, Peters-Klimm F, Schellberg D, et al,. Depression is a major determinant of quality of life in patients with chronic systolic heart failure in general practice. J Card Fail 2007; 13: 818-824.
37. Katon W, Lin EH, Kroenke K,. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007; 29: 147-155.
38. Ell K, Xie B, Quon B, Quinn DI, Dwight-Johnson M, Lee PJ,. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol 2008; 26: 4488-4496.
39. Strong V, Waters R, Hibberd C, et al,. Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet 2008; 372: 40-48.
40. Hutter N, Vogel B, Alexander T, Baumeister H, Helmes A, Bengel J,. Are depression and anxiety determinants or indicators of quality of life in breast cancer patients? Psychol Health Med 2013; 18: 412-419.